APA (7th ed.) Citation

DJ, S., DH, B., C, C., M, S., KE, S., SR, W., . . . F, T. (2023). Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study. The Journal of infectious diseases, 227(8), 939. https://doi.org/10.1093/infdis/jiac445

Chicago Style (17th ed.) Citation

DJ, Stieh, et al. "Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study." The Journal of Infectious Diseases 227, no. 8 (2023): 939. https://doi.org/10.1093/infdis/jiac445.

MLA (9th ed.) Citation

DJ, Stieh, et al. "Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study." The Journal of Infectious Diseases, vol. 227, no. 8, 2023, p. 939, https://doi.org/10.1093/infdis/jiac445.